All-trans retinoic acid and rapamycin synergize with transforming growth factor-β1 to induce regulatory T cells but confer different migratory capacities

Journal of Leukocyte Biology

Volumn 94, Issue 5, 2013, Pages 981-989

  Jhunjhunwala, Siddharth ^a,c   Chen, Leo C ^b   Nichols, Erin E ^c   Thomson, Angus W ^b,d   Raimondi, Giorgio ^b,e   Little, Steven R ^a,b,c,d,e  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adoptive cell; Chemokines; Inflammatory bowel disease; Live animal imaging; Therapy; Treg migration

Indexed keywords

RAPAMYCIN; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL POPULATION; CELL STIMULATION; COLITIS; CONTROLLED STUDY; IN VIVO STUDY; LYMPHOID TISSUE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ADOPTIVE CELL THERAPY; CHEMOKINES; INFLAMMATORY BOWEL DISEASE; LIVE-ANIMAL IMAGING; TREG MIGRATION;

ANIMALS; ANTIGENS, CD; CELL MOVEMENT; DRUG SYNERGISM; INTEGRIN ALPHA CHAINS; MICE; MICE, INBRED C57BL; RECEPTORS, CCR; SIROLIMUS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1; TRETINOIN;

EID: 84887014101     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0312167     Document Type: Article

References (38)

1. Wieckiewicz, J., Goto, R., Wood, K. J. (2010) T regulatory cells and the control of alloimmunity: from characterisation to clinical application. Curr. Opin. Immunol. 22, 662-668.
2. Riley, J. L., June, C. H., Blazar, B. R. (2009) Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 30, 656-665.
3. Brusko, T. M., Putnam, A. L., Bluestone, J. A. (2008) Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol. Rev. 223, 371-390.
4. Trzonkowski, P., Bieniaszewska, M., Juscinska, J., Dobyszuk, A., Krzystyniak, A., Marek, N., Myskiwska, J., Hellmann, A. (2009) First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4 CD25 CD127 T regulatory cells. Clin. Immunol. 133, 22-26.
5. Brunstein, C. G., Miller, J. S., Cao, Q., McKenna, D. H., Hippen, K. L., Curtsinger, J., DeFor, T., Levine, B. L., June, C. H., Rubinstein, P., McGlave, P. B., Blazar, B. R., Wagner, J. E. (2011) Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117, 1061-1070.
6. Safinia, N., Sagoo, P., Lechler, R., Lombardi, G. (2010) Adoptive regulatory T cell therapy: challenges in clinical transplantation. Curr. Opin. Organ Transplant. 15, 427-434.
7. Fu, S., Zhang, N., Yopp, A. C., Chen, D., Mao, M., Zhang, H., Ding, Y., Bromberg, J. S. (2004) TGFinduces FoxP3 T-regulatory cells from CD4 CD25 precursors. Am. J. Transplant. 4, 1614-1627.
8. Chen, W., Jin, W., Hardegen, N., Lei, K. J., Li, L., Marinos, N., McGrady, G., Wahl, S. M. (2003) Conversion of peripheral CD4 CD25 naive T cells to CD4 CD25 regulatory T cells by TGFinduction of transcription factor FoxP3. J. Exp. Med. 198, 1875-1886.
9. Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J., Schlawe, K., Chang, H. D., Bopp, T., Schmitt, E., Klein-Hessling, S., Serfling, E., Hamann, A., Huehn, J. (2007) Epigenetic control of the FoxP3 locus in regulatory T cells. PLoS Biol. 5, e38.
10. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., Stockinger, B. (2006) TGFin the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189.
11. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., Kuchroo, V. K. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238.
12. Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., Cheroutre, H. (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256-260.
13. Lu, L., Zhou, X., Wang, J., Zheng, S. G., Horwitz, D. A. (2011) Characterization of protective human CD4 CD25 FOXP3 regulatory T cells generated with IL-2, TGFand retinoic acid. PLoS One 5, 1-12.
14. Benson, M. J., Pino-Lagos, K., Rosemblatt, M., Noelle, R. J. (2007) Alltrans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204, 1765-1774.
15. DePaolo, R. W., Abadie, V., Tang, F., Fehlner-Peach, H., Hall, J. A., Wang, W., Marietta, E. V., Kasarda, D. D., Waldmann, T. A., Murray, J. A., Semrad, C., Kupfer, S. S., Belkaid, Y., Guandalini, S., Jabri, B. (2011) Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 471, 220-224.
16. Jones, D. H. (1989) The role and mechanism of action of 13-cis-retinoic acid in the treatment of severe (nodulocystic) acne. Pharmacol. Ther. 40, 91-106.
17. Barua, A. B., Olson, J. A. (1996) Percutaneous absorption, excretion and metabolism of all-trans-retinoyl beta-glucuronide and of all-transretinoic acid in the rat. Skin Pharmacol. 9, 17-26.
18. Kopf, H., de la Rosa, G. M., Howard, O. M. Z., Chen, X. (2007) Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3 T regulatory cells. Int. Immunopharmacol. 7, 1819-1824.
19. Haxhinasto, S., Mathis, D., Benoist, C. (2008) The AKT-mTOR axis regulates de novo differentiation of CD4 FoxP3 cells. J. Exp. Med. 205, 565-574.
20. Cobbold, S. P., Adams, E., Farquhar, C. A., Nolan, K. F., Howie, D., Lui, K. O., Fairchild, P. J., Mellor, A. L., Ron, D., Waldmann, H. (2009) Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc. Natl. Acad. Sci. USA 106, 12055-12060.
21. Hill, J. A., Hall, J. A., Sun, C. M., Cai, Q., Ghyselinck, N., Chambon, P., Belkaid, Y., Mathis, D., Benoist, C. (2008) Retinoic acid enhances FoxP3 induction indirectly by relieving inhibition from CD4 CD44hi cells. Immunity 29, 758-770.
22. Mucida, D., Kutchukhidze, N., Erazo, A., Russo, M., Lafaille, J. J., Curotto De Lafaille, M. A. (2005) Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115, 1923-1933.
23. Liu, V. C., Wong, L. Y., Jang, T., Shah, A. H., Park, I., Yang, X., Zhang, Q., Lonning, S., Teicher, B. A., Lee, C. (2007) Tumor evasion of the immune system by converting CD4 CD25 T cells into CD4 CD25 T regulatory cells: role of tumor-derived TGF-. J. Immunol. 178, 2883-2892.
24. Cobbold, S. P., Castejon, R., Adams, E., Zelenika, D., Graca, L., Humm, S., Waldmann, H. (2004) Induction of foxP3 regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J. Immunol. 172, 6003-6010.
25. Campbell, D. J., Koch, M. A. (2011) Phenotypical and functional specialization of FOXP3 regulatory T cells. Nat. Rev. Immunol. 11, 119-130.
26. Yamaguchi, T., Hirota, K., Nagahama, K., Ohkawa, K., Takahashi, T., Nomura, T., Sakaguchi, S. (2007) Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 27, 145-159.
27. Barnes, M. J., Powrie, F. (2009) Hybrid Treg cells: steel frames and plastic exteriors. Nat. Immunol. 10, 563-564.
28. Koch, M. A., Tucker-Heard, G., Perdue, N. R., Killebrew, J. R., Urdahl, K. B., Campbell, D. J. (2009) The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595-602.
29. Zheng, Y., Chaudhry, A., Kas, A., deRoos, P., Kim, J. M., Chu, T. T., Corcoran, L., reuting, P., Klein, U., Rudensky, A. Y. (2009) Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458, 351-356.
30. Murphy, K. M., Stockinger, B. (2010) Effector T cell plasticity: flexibility in the face of changing circumstances. Nat. Immunol. 11, 674-680.
31. Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martinez Llordella, M., Ashby, M., Nakayama, M., Rosenthal, W., Bluestone, J. A. (2009) Instability of the transcription factor FoxP3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007.
32. Lee, Y. K., Mukasa, R., Hatton, R. D., Weaver, C. T. (2009) Developmental plasticity of Th17 and Treg cells. Curr. Opin. Immunol. 21, 274-280.
33. Jhunjhunwala, S., Raimondi, G., Thomson, A. W., Little, S. R. (2009) Delivery of rapamycin to dendritic cells using degradable microparticles. J. Control Rel. 133, 191-197.
34. Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., Powrie, F. (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995-1004.
35. Housley, W. J., Adams, C. O., Nichols, F. C., Puddington, L., Lingenheld, E. G., Zhu, L., Rajan, T. V., Clark, R. B. (2011) Natural but not inducible regulatory T cells require TNF-÷ signaling for in vivo function. J. Immunol. 186, 6779-6787.
36. Issa, F., Hester, J., Milward, K., Wood, K. J. (2012) Homing of regulatory T cells to human skin is important for the prevention of alloimmunemediated pathology in an in vivo cellular therapy model. PLoS One 7, e53331.
37. Lan, Q., Fan, H., Quesniaux, V., Ryffel, B., Liu, Z., Zheng, S. G. (2012) Induced FoxP3() regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? J. Mol. Cell. Biol. 4, 22-28.
38. Jhunjhunwala, S., Balmert, S. C., Raimondi, G., Dons, E., Nichols, E. E., Thomson, A. W., Little, S. R. (2012) Controlled release formulations of IL-2, TGF-1 and rapamycin for the induction of regulatory T cells. J. Control Release 159, 78-84.